Derek Angus
Pittsburgh, PANPI 1407828890
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,050 of the $14,253 with a category attached, or 91.6%. Ferring Pharmaceuticals AS accounts for 89.7% of it on its own, with 2 other manufacturers making up the rest.
Across 13 payments — averaging $1096.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals AS$13K
- Merck Kgaa$1K
- Ferring Pharmaceuticals Inc.$420
Across 4 payments — averaging $1,050,375 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$4.2M
What the payments were for
- Consulting fees$13,05092%
- Travel & lodging$9777%
- Food & beverage$2262%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals AS | 7 | $12,783 |
| Merck Kgaa | 2 | $1,050 |
| Ferring Pharmaceuticals Inc. | 4 | $420 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.